{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:09:12Z","timestamp":1784038152812,"version":"3.55.0"},"reference-count":60,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Heterogeneous nuclear ribonucleoprotein U (hnRNPU) is a ubiquitously expressed, pleiotropic DNA and RNA binding protein involved in RNA metabolism. Heterozygous HNRNPU nonsense mutations have been observed in a variety of B-cell lymphomas, but the functional consequence of these mutations remains largely unknown. Through a large meta-analysis of genome- and exome-wide sequencing data, we find that these mutations are more common among tumors with MYC rearrangements, including high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements (12.1%), and Burkitt lymphoma (5.2%). Using isogenic cell line models, we demonstrate that HNRNPU is a haploinsufficient tumor suppressor, with inactivation of a single allele promoting cell cycle entry through widespread alteration of the gene expression and splicing landscape. We show that reduced hnRNPU expression consistently lowers MYC levels while simultaneously enhancing E2F-driven signaling. This creates a cellular state in which MYC-induced stress may be buffered while cell cycle progression is maintained. Finally, we show that owing to this increased dependence on E2Fs for proliferative signaling, HNRNPU-mutated lymphomas are more sensitive to E2F inhibitors. These results highlight hnRNPU-mediated regulation of MYC and its downstream effects as possible new avenues for therapeutic intervention in MYC-driven lymphomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019135","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:07:41Z","timestamp":1778677661000},"page":"4828-4841","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["<i>HNRNPU<\/i>\n                    mutations redirect cell cycle control to E2F in MYC-driven lymphomas"],"prefix":"10.1182","volume":"10","author":[{"given":"Qurat Ul Ain","family":"Qureshi","sequence":"first","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"2Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-4873","authenticated-orcid":false,"given":"Krysta M.","family":"Coyle","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"2Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6479-7647","authenticated-orcid":false,"given":"Callum","family":"Brown","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"2Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Thomas","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"2Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-2798","authenticated-orcid":false,"given":"Brett","family":"Collinge","sequence":"additional","affiliation":[{"name":"3BC Cancer\u2019s Centre for Lymphoid Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostiantyn","family":"Dreval","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"2Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-9750","authenticated-orcid":false,"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"3BC Cancer\u2019s Centre for Lymphoid Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-5947","authenticated-orcid":false,"given":"David W.","family":"Scott","sequence":"additional","affiliation":[{"name":"3BC Cancer\u2019s Centre for Lymphoid Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8342-2713","authenticated-orcid":false,"given":"Timothy E.","family":"Audas","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-7800","authenticated-orcid":false,"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"2Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada"},{"name":"3BC Cancer\u2019s Centre for Lymphoid Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"15","key":"2026071409580643600_bib1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"2026071409580643600_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"8","key":"2026071409580643600_bib3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/bloodadvances.2022009461","article-title":"Audit of B-cell cancer genes","volume":"9","author":"Coyle","year":"2025","journal-title":"Blood Adv"},{"issue":"7","key":"2026071409580643600_bib4","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","article-title":"Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas","volume":"35","author":"H\u00fcbschmann","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"2026071409580643600_bib5","first-page":"29","article-title":"Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies","volume":"4","author":"Sun","year":"2018","journal-title":"Chronic Dis Transl Med"},{"issue":"6","key":"2026071409580643600_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1947601910378024","article-title":"Myc: the beauty and the beast","volume":"1","author":"Wasylishen","year":"2010","journal-title":"Genes Cancer"},{"issue":"4","key":"2026071409580643600_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bcmd.2010.08.002","article-title":"The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma","volume":"45","author":"Smith","year":"2010","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2026071409580643600_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/genes8040116","article-title":"The role of c-MYC in B-cell lymphomas: diagnostic and molecular aspects","volume":"8","author":"Nguyen","year":"2017","journal-title":"Genes"},{"issue":"35","key":"2026071409580643600_bib9","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"issue":"20","key":"2026071409580643600_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2026071409580643600_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/bloodadvances.2025017282","article-title":"Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC\/BCL2 rearrangements, DLBCL morphology","volume":"10","author":"Alduaij","year":"2026","journal-title":"Blood Adv"},{"issue":"5","key":"2026071409580643600_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.2019002385","article-title":"Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing","volume":"136","author":"Pararajalingam","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2026071409580643600_bib13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"issue":"2","key":"2026071409580643600_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1139\/bcb-2022-0332","article-title":"Emerging roles for heterogeneous ribonuclear proteins in normal and malignant B cells","volume":"101","author":"Qureshi","year":"2023","journal-title":"Biochem Cell Biol"},{"issue":"23","key":"2026071409580643600_bib15","doi-asserted-by":"crossref","first-page":"E3020","DOI":"10.1073\/pnas.1508461112","article-title":"hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function","volume":"112","author":"Ye","year":"2015","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"2026071409580643600_bib16","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1002\/j.1460-2075.1992.tb05422.x","article-title":"Characterization of SAF-A, a novel nuclear DNA binding protein from HeLa cells with high affinity for nuclear matrix\/scaffold attachment DNA elements","volume":"11","author":"Romig","year":"1992","journal-title":"EMBO J"},{"key":"2026071409580643600_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcdb.2022.04.018","article-title":"Nuclear organization by satellite DNA, SAF-A\/hnRNPU and matrix attachment regions","volume":"128","author":"Podgornaya","year":"2022","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"2026071409580643600_bib18","doi-asserted-by":"crossref","first-page":"2300039","DOI":"10.1002\/bies.202300039","article-title":"HNRNPU\u2019s multi-tasking is essential for proper cortical development","volume":"45","author":"Sapir","year":"2023","journal-title":"BioEssays"},{"issue":"12","key":"2026071409580643600_bib19","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1101\/gr.222109.117","article-title":"GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly","volume":"27","author":"Cameron","year":"2017","journal-title":"Genome Res"},{"issue":"8","key":"2026071409580643600_bib20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","article-title":"Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications","volume":"32","author":"Chen","year":"2016","journal-title":"Bioinforma Oxf Engl"},{"issue":"1","key":"2026071409580643600_bib21","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1038\/s41467-020-14743-w","article-title":"An integrative ENCODE resource for cancer genomics","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"2026071409580643600_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13059-017-1364-2","article-title":"PureCLIP: capturing target-specific protein\u2013RNA interaction footprints from single-nucleotide CLIP-seq data","volume":"18","author":"Krakau","year":"2017","journal-title":"Genome Biol"},{"issue":"12","key":"2026071409580643600_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"51","key":"2026071409580643600_bib24","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2026071409580643600_bib25","doi-asserted-by":"crossref","first-page":"e20230891","DOI":"10.1084\/jem.20230891","article-title":"Aberrant pre-mRNA processing in cancer","volume":"221","author":"Biswas","year":"2024","journal-title":"J Exp Med"},{"issue":"3","key":"2026071409580643600_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","article-title":"RNA splicing dysregulation and the hallmarks of cancer","volume":"23","author":"Bradley","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"D1","key":"2026071409580643600_bib27","doi-asserted-by":"crossref","first-page":"D125","DOI":"10.1093\/nar\/gks997","article-title":"SpliceAid-F: a database of human splicing factors and their RNA-binding sites","volume":"41","author":"Giulietti","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026071409580643600_bib28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fimmu.2020.00788","article-title":"AID overlapping and Pol\u03b7 hotspots are key features of evolutionary variation within the human antibody heavy chain (IGHV) genes","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"issue":"6166","key":"2026071409580643600_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"issue":"6","key":"2026071409580643600_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"42","key":"2026071409580643600_bib31","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1038\/sj.onc.1205828","article-title":"E2F activity is essential for survival of Myc-overexpressing human cancer cells","volume":"21","author":"Santoni-Rugiu","year":"2002","journal-title":"Oncogene"},{"issue":"5","key":"2026071409580643600_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/blood.2024024251","article-title":"Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)","volume":"144","author":"Hilton","year":"2024","journal-title":"Blood"},{"key":"2026071409580643600_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2026071409580643600_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/187152012800617678","article-title":"The role of Cdc25A in the regulation of cell proliferation and apoptosis","volume":"12","author":"Shen","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"2026071409580643600_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13046-022-02558-0","article-title":"SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis","volume":"41","author":"Liu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"2026071409580643600_bib36","doi-asserted-by":"crossref","first-page":"e50615","DOI":"10.15252\/embr.202050615","article-title":"MDM2 regulates RB levels during genotoxic stress","volume":"22","author":"Hernandez-Monge","year":"2021","journal-title":"EMBO Rep"},{"issue":"8","key":"2026071409580643600_bib37","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1007\/s11033-023-08512-3","article-title":"MDM2- an indispensable player in tumorigenesis","volume":"50","author":"Zafar","year":"2023","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2026071409580643600_bib38","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar4483","article-title":"CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction","volume":"16","author":"Ito","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2026071409580643600_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","article-title":"Induction of apoptosis in fibroblasts by c-myc protein","volume":"69","author":"Evan","year":"1992","journal-title":"Cell"},{"issue":"50","key":"2026071409580643600_bib40","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Hoffman","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"2026071409580643600_bib41","doi-asserted-by":"crossref","first-page":"e11845","DOI":"10.15252\/emmm.201911845","article-title":"MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?","volume":"12","author":"Zhang","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"19","key":"2026071409580643600_bib42","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.molcel.2021.07.041","article-title":"Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis","volume":"81","author":"Gong","year":"2021","journal-title":"Mol Cell"},{"issue":"7","key":"2026071409580643600_bib43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","article-title":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor","volume":"107","author":"Yoshida","year":"2001","journal-title":"Cell"},{"issue":"5","key":"2026071409580643600_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/cells8050390","article-title":"Telomere function and the G-quadruplex formation are regulated by hnRNP U","volume":"8","author":"Izumi","year":"2019","journal-title":"Cells"},{"issue":"15","key":"2026071409580643600_bib45","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1158\/0008-5472.CAN-08-0121","article-title":"A small-molecule E2F inhibitor blocks growth in a melanoma culture model","volume":"68","author":"Ma","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"2026071409580643600_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/ijms20010120","article-title":"Therapeutic inhibition of Myc in cancer. Structural bases and computer-aided drug discovery approaches","volume":"20","author":"Carabet","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2026071409580643600_bib47","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1080\/15384101.2016.1164372","article-title":"Aberrant hnRNP K expression: all roads lead to cancer","volume":"15","author":"Gallardo","year":"2016","journal-title":"Cell Cycle"},{"issue":"1","key":"2026071409580643600_bib48","doi-asserted-by":"crossref","first-page":"112898","DOI":"10.1016\/j.yexcr.2021.112898","article-title":"HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription","volume":"409","author":"Liang","year":"2021","journal-title":"Exp Cell Res"},{"issue":"11","key":"2026071409580643600_bib49","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41419-022-05376-6","article-title":"HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms","volume":"13","author":"Han","year":"2022","journal-title":"Cell Death Dis"},{"issue":"7","key":"2026071409580643600_bib50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/cns.13295","article-title":"Expression and prognostic role of E2F transcription factors in high-grade glioma","volume":"26","author":"Yu","year":"2020","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"2026071409580643600_bib51","first-page":"1133","article-title":"Integrated analysis of the E2F transcription factors across cancer types","volume":"43","author":"Wang","year":"2020","journal-title":"Oncol Rep"},{"issue":"9","key":"2026071409580643600_bib52","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1158\/0008-5472.CAN-08-4617","article-title":"E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt\u2019s lymphoma","volume":"69","author":"Molina-Privado","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"2026071409580643600_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/cc.2.4.428","article-title":"E2F1 and c-Myc in cell growth and death","volume":"2","author":"Matsumura","year":"2003","journal-title":"Cell Cycle"},{"issue":"12","key":"2026071409580643600_bib54","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1182\/bloodadvances.2025016180","article-title":"The role of miR-150-5p\/E2F3\/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential","volume":"9","author":"Verd\u00fa-Bou","year":"2025","journal-title":"Blood Adv"},{"issue":"2","key":"2026071409580643600_bib55","doi-asserted-by":"crossref","first-page":"e1106635","DOI":"10.1080\/23723556.2015.1106635","article-title":"MDM2\/MDMX: master negative regulators for p53 and RB","volume":"3","author":"Hu","year":"2016","journal-title":"Mol Cell Oncol"},{"issue":"2","key":"2026071409580643600_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"Felsher","year":"1999","journal-title":"Mol Cell"},{"issue":"13","key":"2026071409580643600_bib57","first-page":"1019","article-title":"Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis","volume":"135","author":"Nguyen","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2026071409580643600_bib58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1097-2765(03)00102-3","article-title":"Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss","volume":"11","author":"Baudino","year":"2003","journal-title":"Mol Cell"},{"issue":"3","key":"2026071409580643600_bib59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/genes10030244","article-title":"MYC oncogene contributions to release of cell cycle brakes","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2019","journal-title":"Genes"},{"key":"2026071409580643600_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chembiol.2020.12.014","article-title":"Nailing down a notoriously elusive cancer target: direct inhibition of MYC by a covalent small molecule","volume":"28","author":"Henley","year":"2021","journal-title":"Cell Chem Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4828\/2531579\/blooda_adv-2025-019135-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4828\/2531579\/blooda_adv-2025-019135-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:58:20Z","timestamp":1784037500000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/13\/4828\/568367\/HNRNPU-mutations-redirect-cell-cycle-control-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":60,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019135","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,14]]},"published":{"date-parts":[[2026,7,2]]}}}